about
Influence of the gestational stage on the clinical course, lesional development and parasite distribution in experimental ovine neosporosis.Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice.Systemic and local immune responses in sheep after Neospora caninum experimental infection at early, mid and late gestation.Neospora caninum infection during early pregnancy in cattle: how the isolate influences infection dynamics, clinical outcome and peripheral and local immune responses.Tritrichomonas foetus infection in cats with diarrhea from densely housed origins.Dose-dependent effects of experimental infection with the virulent Neospora caninum Nc-Spain7 isolate in a pregnant mouse model.A vaccine formulation combining rhoptry proteins NcROP40 and NcROP2 improves pup survival in a pregnant mouse model of neosporosis.Toxoplasma CRISPR/Cas9 constructs are functional for gene disruption in Neospora caninum.First description of naturally acquired Tritrichomonas foetus infection in a Persian cattery in Spain.Multilocus analysis reveals further genetic differences between Tritrichomonas foetus from cats and cattleSerotyping of Toxoplasma gondii Infection Using Peptide Membrane ArraysImmunization with a cocktail of antigens fused with OprI reduces Neospora caninum vertical transmission and postnatal mortality in miceToxoplasma GRA15 and GRA24 are important activators of the host innate immune response in the absence of TLR11
P50
Q35136452-07CE2512-5F1E-4A48-AC9E-D5FF061BE94EQ35547951-CB2E1D2D-2FA0-4517-AEF6-44F8598367F8Q36433149-5036CCAB-331F-4E7A-BF90-D234060ABEC9Q37580784-5BDAA836-446D-4FBA-B420-11F6466FCD2BQ40712133-864C2B55-CC63-403B-8744-82860F79BC70Q41143239-4011D185-ED55-4C36-8819-7F1B6139153FQ41550534-AF05B5A9-2E65-4ED8-9557-0BE6317A05D5Q52431356-78D8230E-42AF-49EA-A51D-612D737F48B8Q54376770-F8AFD0E2-FDDF-4338-9315-96F57D016B16Q91281586-A82A6EF7-D38E-44EB-B119-E50B46A14D6AQ92074119-2A03E229-38DF-427D-A837-1040BDB5A25DQ93375279-7140ACEC-D20A-4F9D-8DCF-A18612943A05Q95846053-9C23CC18-0B17-42E2-9B29-C8F9E909531D
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
David Arranz-Solís
@en
David Arranz-Solís
@nl
type
label
David Arranz-Solís
@en
David Arranz-Solís
@nl
prefLabel
David Arranz-Solís
@en
David Arranz-Solís
@nl
P31
P496
0000-0002-2647-3194